|
李朋梅 |
|
|
副主任药师，专硕导师 |
|
|
研究领域：治疗药物监测及个体化给药 |
|
|
电话：（010）84205370 |
|
|
电子邮箱：lipengmei@yeah.net |
|
教育背景 |
|
|
中国药科大学硕士（2005） |
|
|
中国药科大学学士（2002） |
|
|
工作经历 |
|
|
2018.01-至今 中日友好医院药学部，副主任，党支部书记 |
|
|
2015.07-至今 中日友好医院药学部，副主任药师 |
|
|
2010.07-2015.06 中日友好医院药学部，主管药师 |
|
|
2005.08-2010.06 中日友好医院药学部，药师 |
|
|
社会兼职 |
|
|
2019.12.15至2023.12.15，中国药学会医院药学专业委员会委员 |
|
|
2018.12.13至2022.12.13，中国药学会医药信息专业委员会委员 |
|
|
2019.08.29至2022.08.29，中国药理学会治疗药物监测研究专业委员会委员 |
|
|
代表性论文（近一年） |
|
|
1Wang Xiaoxue,Qin Wei,Chen Wenqian,Liu Huifang,Li Pengmei*.Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay .EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21(3):191. |
|
|
2 Du Wen-Wen,Wang Xiao-Xing,Zhang Dan,Chen Wen-Qian,Li Peng-Mei*. Retrospective analysis on incidence and risk factors of early onset acute kidney injury after lung transplantation and its association with mortality .RENAL FAILURE,2021,43(1):535-542.. |
|
|
3 Chen Wenqian,Liu Huifang,Wang Qianlin,Wang Xiaoxing, Li Pengmei*.Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia .EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77(1):95-105.. |
|
|
4 Qin Wei,Wang Xiaoxue,Chen Wenqian,Du Wenwen, Li Pengmei*. An in vitro approach to simulate the process of 5-fluorouracil degradation with dihydropyrimidine dehydrogenase: the process in accordance to the first-order kinetic reaction .XENOBIOTICA, 2021, 51(1):24-30. |
|
|
5 Zhang Dan,Hu Min,Xu Chengbo,Chen Chengjuan, Li Pengmei*.Pharmacokinetic Characterization of ZT55, A Novel Indole Derivative Isolated from Radix Isatidis, using Liquid Chromatography/Tandem Mass and Q-TOF/Tandem Mass Spectrometry .CURRENT PHARMACEUTICAL ANALYSIS, 2021,17(2):210-221. |
|
|
6 Qin W, Zhang L, Xu L, Zhao L, Yang Q,Li P*, Fan B*. Effect of Continuing Nursing Education on the Quality of Nursing Management of Cancer Pain in China. J Contin Educ Nurs. 2021 Nov;52(11):535-540. |
|
|
7 Wang Xiaoxing,Du Wenwen,Zhang Xianglin*,Li Pengmei*. T.he Influence of Different Disease States on Rituximab Pharmacokinetics . CURRENT DRUG METABOLISM, 2020,21(12):938-946. |
|
|
8 Zhang Dan,Ding Yangming,Wang Xiaoxue,Xin Wenyu,Li Pengmei*. Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin .EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020,76(7):939-946.. |
|
|
9 Chen Wenqian,Zhang Dan,Lian Wenwen,Wang Xiaoxue, Li Pengmei*.Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation .ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64(6). 10Qin Wangjun,Zhang Lei,Tang Kun,Zhao Li,Li Pengmei*.Effect of heat shock protein 70 modulators on the development of morphine analgesic tolerance in rats .BEHAVIOURAL PHARMACOLOGY, 2020,31(2-3):179-185. |
|
|
11张丹,陈文倩,秦伟,杜雯雯,李朋梅*.利伐沙班导致出血事件的群体药动学模型建立及影响因素分析.中国医院药学杂志,2021，41 (14):1446-1449. |
|
|
12杜雯雯,王晓星,张丹,李朋梅*.肺移植患者术后使用他克莫司1年CYP3A5、CYP3A4、ABCB1、POR~*28基因多态性与他克莫司个体化用药的关系研究. 中国药房, 2020, 31(1):80-85. |
|
|
13张丹,辛文妤,杜雯雯,陈文倩, 李朋梅*.SLCO1B1和APOE基因多态性对瑞舒伐他汀调脂疗效及不良反应的影响.中国新药与临床杂志, 2020,39(1):31-36. |
|
|
14陈文倩,刘慧芳,王芊霖,王晓星, 李朋梅*.基于治疗药物监测的多粘菌素B用药方案优化.中国新药杂志, 2020, 29(7):836-840. |
|
|
15陈文倩,王晓雪,刘慧芳,杜雯雯, 李朋梅*.有限采样法估算重症感染患者卡泊芬净的药-时曲线下面积.中国药业, 2020, 29(13):9-13. |
|
|
16王晓雪,刘慧芳,秦伟,张丹, 李朋梅*.不同品牌蛋白沉淀板对人血浆中霉酚酸含量测定结果比较. 中国医院药学杂志:2021,1-6. |
|
|
17陈文倩,王晓雪,刘慧芳,杜雯雯, 李朋梅*.2型糖尿病肾病及非肾病患者同型半胱氨酸及叶酸等9种维生素水平分析.中国药学杂志, 2020,55(14):1154-1157. |
|
|
|
|
|
荣誉奖励 |
|
|
2020年，中日友好医院优秀教学管理者 |
|
|
2017年，中日友好医院2017年度重大专项工作奖 |
|
|
2012年，中日友好医院创先争优活动先进个人 |
|
|
2010年，中日友好医院优秀住院医师 |
|